Pulmonx Corporation LUNG
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 25.02% | 15.50% | 6.80% | 4.24% | 0.62% |
| Total Depreciation and Amortization | -18.82% | -26.30% | -31.22% | -22.71% | -12.19% |
| Total Amortization of Deferred Charges | 523.53% | 343.48% | 266.04% | -190.38% | -133.12% |
| Total Other Non-Cash Items | -20.47% | -15.11% | -12.19% | -10.27% | -8.74% |
| Change in Net Operating Assets | -565.32% | -308.88% | 168.93% | -13.04% | 118.70% |
| Cash from Operations | 20.12% | 1.75% | 11.26% | -2.66% | 3.71% |
| Capital Expenditure | 94.36% | 87.23% | 87.66% | 68.76% | 64.19% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | -79.76% | -61.91% | 63.47% | 1,959.91% |
| Cash from Investing | -100.07% | -79.61% | -60.99% | 74.42% | 6,713.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -37,760.20% | -38,152.58% | -38,952.63% | -5.26% | -5.38% |
| Issuance of Common Stock | -45.04% | -56.26% | -53.90% | -31.21% | -28.56% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -624.29% | -927.66% | -- | -- | -- |
| Cash from Financing | 105.83% | 56.44% | 88.74% | -38.88% | -36.27% |
| Foreign Exchange rate Adjustments | 112.14% | 180.94% | -12.99% | -221.05% | 57.19% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -280.23% | -263.47% | -393.87% | 90.87% | 141.88% |